Ticker Details
Cardiff Oncology, Inc.
IPO Date:	August 1, 2004
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$68.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 4.61%
Avg Daily Range (30 D):	$0.04 | 3.93%
Avg Daily Range (90 D):	$0.05 | 3.79%

Institutional Daily Volume
Avg Daily Volume:	.95M
Avg Daily Volume (30 D):	1.14M
Avg Daily Volume (90 D):	1.11M

Trade Size
Avg Trade Size (Sh.):	180
Avg Trade Size (Sh.) (30 D):	308
Avg Trade Size (Sh.) (90 D):	233

Institutional Trades
Total Institutional Trades:	178
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$6.16M
Avg Institutional Trade (90 D):	$6.16M
Avg Institutional Trade Volume:	.28M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.15M
Avg Closing Trade (30 D):	$6.16M
Avg Closing Trade (90 D):	$6.16M
Avg Closing Volume:	443.03K

News

May 21, 2026 @ 9:00 PM Cardiff Oncology Announces Webcast to Discuss Upda... Source: Cardiff Oncology, Inc.

Apr 21, 2026 @ 2:00 PM Cardiff Oncology to Present Updated Phase 2 Data o... Source: Na

Mar 19, 2026 @ 11:00 AM Cardiff Oncology to Present Preclinical Data with ... Source: Na

Nov 24, 2025 @ 12:00 PM Cardiff Oncology to Present at the Piper Sandler 3... Source: Cardiff Oncology, Inc.

Nov 12, 2025 @ 6:00 PM KRAS Inhibitors Market to Witness Explosive Growth... Source: Delveinsight

Financials
	TTM	Q1 2026	Q3 2025
Basic EPS	$-.14	$-.18	$-.17
Diluted EPS	$-.14	$-.18	$-.17
Revenue	$.1M	$.04M	$.12M
Gross Profit
Net Income / Loss	$-9.23M	$-12.35M	$-11.26M
Operating Income / Loss	$-9.62M	$-12.85M	$-11.97M
Cost of Revenue
Net Cash Flow	$.65M	$-8.93M	$-.65M
PE Ratio

Splits
Feb 20, 2019	1:6
Jun 04, 2018	1:12
May 30, 2012	1:6